June 5, 2019
The Ministry of Health, Labor and Welfare (MHLW) on June 4 ordered label revisions related to adverse reactions for a batch of drugs including Shionogi’s novel flu drug Xofluza (baloxavir marboxil) and immune checkpoint inhibitors. Xofluza will add shock and...read more